Angle’s JNJ-trumping Liquid Biopsy System Could See Five-fold Jump In Near-Term Sales
UK-based Angle plc began developing its circulating tumor cell capture system, Parsortix only in 2011, but the company is now moving into the commercialization phase and expecting a sharp sales ramp-up over the next couple of years.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.